Efficacy of humanized carbapenem and ceftazidime regimens against Enterobacteriaceae producing OXA-48 carbapenemase in a murine infection model. - Wikidata - wikimedia - TriplyDB

Efficacy of humanized carbapenem and ceftazidime regimens against Enterobacteriaceae producing OXA-48 carbapenemase in a murine infection model.

Efficacy of humanized carbapenem and ceftazidime regimens against Enterobacteriaceae producing OXA-48 carbapenemase in a murine infection model.

http://www.wikidata.org/entity/Q37643634

about

Global Dissemination of Carbapenemase-Producing Klebsiella pneumoniae: Epidemiology, Genetic Context, Treatment Options, and Detection Methods A Flow Cytometric and Computational Approaches to Carbapenems Affinity to the Different Types of Carbapenemases Detection of OXA-48-type carbapenemase-producing Enterobacteriaceae in diagnostic laboratories can be enhanced by addition of bicarbonates to cultivation media or reaction buffers.Carbapenemase-Producing Klebsiella pneumoniae, a Key Pathogen Set for Global Nosocomial Dominance In vivo efficacy of humanized high dose meropenem and comparators against Pseudomonas aeruginosa isolates producing verona integron-encoded metallo-β-lactamase (VIM).Treatment options for infections caused by carbapenem-resistant Enterobacteriaceae: can we apply "precision medicine" to antimicrobial chemotherapy?Optimizing Antibiotic Dosing Strategies for the Treatment of Gram-negative Infections in the Era of Resistance.Efficacy of humanized high-dose meropenem, cefepime, and levofloxacin against Enterobacteriaceae isolates producing Verona integron-encoded metallo-β-lactamase (VIM) in a murine thigh infection model.Treatment of Infections Caused by Extended-Spectrum-Beta-Lactamase-, AmpC-, and Carbapenemase-Producing Enterobacteriaceae.

P2860

Q26744583-7ACDFB8A-30B7-4DFE-A60C-EEBB3F5CCAC1 Q28831094-05E3E607-3739-4D85-869D-02212D4BEA05 Q35083616-2846BBD7-0B56-4813-A1DE-2A6F007B484E Q36076066-D9F6BFE0-6054-4D68-AA9D-E7A5D25DCB1B Q37097371-1B22C24F-24BF-4605-8381-CED8F664B6C1 Q37146405-B15263A1-B23A-4D78-B7A9-0251E0471C37 Q38672016-932137CC-AB0E-4332-B971-53F4E46BCB90 Q40976243-3C418A41-96DA-4AF1-816C-3469D7618C64 Q52695014-67CA2322-F628-4F35-972D-095879D655C4

P2860

Efficacy of humanized carbapenem and ceftazidime regimens against Enterobacteriaceae producing OXA-48 carbapenemase in a murine infection model.

http://www.wikidata.org/entity/Q37643634

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on 30 December 2013

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

Efficacy of humanized carbapen ...... e in a murine infection model.

@en

Efficacy of humanized carbapen ...... e in a murine infection model.

@nl

type

label

Efficacy of humanized carbapen ...... e in a murine infection model.

@en

Efficacy of humanized carbapen ...... e in a murine infection model.

@nl

prefLabel

Efficacy of humanized carbapen ...... e in a murine infection model.

@en

Efficacy of humanized carbapen ...... e in a murine infection model.

@nl

P1433

Q37643634-616A5363-FE6F-4EA3-A8AB-29780066506C

P1476

Q37643634-67C7C390-ED14-40EF-B62C-7532E6174E30

P2093

Q37643634-172E6E43-6B18-4AF5-B68F-28348DE3BDE0

Q37643634-1DC06F48-967E-44DB-BD9B-279E6C36749E

Q37643634-88650E05-87F9-4115-9381-0FA17936D405

P2860

Q37643634-0B91B9C8-B64E-4F80-BC33-458B6392159B

Q37643634-152D1BD5-5715-41FE-8E74-DE30B0E4CFEB

Q37643634-1628B676-8775-4F68-A179-DAD4EF07726A

Q37643634-185A0D5F-C213-4A5F-A15D-35FDD6F8A5C6

Q37643634-2C864011-9A4C-4503-A3CC-74D34DAAE6A8

Q37643634-3B05B4BE-E585-4A46-888D-777F6B86E1D6

Q37643634-3DCB5C5B-4825-43E1-A5D4-92C134A77E8E

Q37643634-4A0AF66A-F544-47C2-A7DF-2AAB6EC31524

Q37643634-528BE8C7-DB64-4FD7-92B6-55AE59532CC6

Q37643634-532BDB13-8771-48FD-B33B-A4953839E441

P304

Q37643634-AA4D90C0-9393-4FD6-88F7-5BF60E40CFC7

P31

Q37643634-7675FBFC-B04B-478E-B6DE-CBF06E81BABE

P356

Q37643634-093C10B9-C59F-476A-AD46-6D4D1DC8EDAD

P407

Q37643634-A3111E64-C80A-4044-BCFA-30F5FD7C8004

P433

Q37643634-B827E8F1-6BA2-4474-A0DD-9C4311F12070

P478

Q37643634-C88DCDF7-3C02-4BD8-B248-1EF2A685B6E5

P50

Q37643634-0B0F423E-96AF-46A9-9E6B-ED66C40BED92

P577

Q37643634-43D35E5B-695C-4CD1-9F58-CE79ED18E529

P698

Q37643634-AB14CA8E-1D7C-4569-BAAB-169EE44247F8

P921

Q37643634-E7C8FFDD-75D1-459C-A312-909F8AB8AEA2

P932

Q37643634-DC4B1845-0D88-433A-BACB-F7E9DB377537

P356

P1433

Antimicrobial Agents and Chemotherapy

P1476

Efficacy of humanized carbapen ...... e in a murine infection model.

@en

P2093

David P Nicolau

http://www.w3.org/2001/XMLSchema#string

Dora E Wiskirchen

http://www.w3.org/2001/XMLSchema#string

Jared L Crandon

http://www.w3.org/2001/XMLSchema#string

P2860

Crystal structure of the OXA-48 beta-lactamase reveals mechanistic diversity among class D carbapenemases

First clinical cases of OXA-48-producing carbapenem-resistant Klebsiella pneumoniae in the United States: the "menace" arrives in the new world

In vivo activities of amoxicillin and amoxicillin-clavulanate against Streptococcus pneumoniae: application to breakpoint determinations.

Emergence of oxacillinase-mediated resistance to imipenem in Klebsiella pneumoniae.

Efficacy of human simulated exposures of ceftaroline administered at 600 milligrams every 12 hours against phenotypically diverse Staphylococcus aureus isolates

Bactericidal activities of meropenem and ertapenem against extended-spectrum-beta-lactamase-producing Escherichia coli and Klebsiella pneumoniae in a neutropenic mouse thigh model

Pharmacodynamics of intravenous ciprofloxacin in seriously ill patients.

Global spread of Carbapenemase-producing Enterobacteriaceae

Broad-spectrum β-lactam antibiotics for treating experimental peritonitis in mice due to Klebsiella pneumoniae producing the carbapenemase OXA-48.

Comparative in vitro and in vivo efficacies of human simulated doses of ceftazidime and ceftazidime-avibactam against Pseudomonas aeruginosa.

P304

1678-1683

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1128/AAC.01947-13

http://www.w3.org/2001/XMLSchema#string

P407

P433

3

http://www.w3.org/2001/XMLSchema#string

P478

58

http://www.w3.org/2001/XMLSchema#string

P50

Patrice Nordmann

P577

2013-12-30T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

24379200

http://www.w3.org/2001/XMLSchema#string

P921

carbapenem antibiotic

P932

3957853

http://www.w3.org/2001/XMLSchema#string